A north India-based semiconductor startup Sophrosyne Technologies is betting that the Manipal–Udupi belt’s clinical ecosystem can do what big-city tech parks often struggle with: shorten the distance between an engineering lab and a real patient use case.
Sophrosyne Technologies, an Indian semiconductor startup focused on healthcare technologies, has set up its research and development and product design centre in Udupi, according to its founder and CEO Manish Srivastava. The company, which began with a small office in Udupi about a year ago, formally inaugurated a larger facility on Saturday, its co-founder and chief business officer Jatin Gupta said.
Funding and Government support
Sophrosyne raised $2 million in seed funding from Bluehill VC, Gupta said. The startup has also secured a $1.2 million grant under the Union government’s Design Linked Incentive (DLI) programme, according to the same report.
From a six-person launch team to 30 people in a year
Srivastava said the Udupi office started with six full-time employees and four external consultants, and over the past year the workforce has grown to 30 members, including in-house professionals and domain experts.
The next phase is framed as a hiring-and-training play as much as a technology sprint. “We plan to build a strong entry-level talent pipeline and groom engineers into mid-level roles, complemented by selective lateral hiring for critical positions,” Srivastava said, adding that the aim is to scale the team to over 50 professionals focused on product development and commercialisation within the next 18 months.
What the Udupi centre will work on?
The company says it is exploring multiple focus areas, real-time health monitoring, smart surgical navigation systems, brain health chipsets, and RF-based energy-harvesting technologies designed to extend the life of implantable and wearable devices.
Sophrosyne’s work on a single low-power system-on-chip (SoC) capable of measuring multiple vital parameters such as ECG, PPG, temperature, and respiration, with the technology aimed at healthcare wearables and AI-driven models that deliver real-time health insights.
Why Udupi: the “clinical proximity” argument
Although the startup is headquartered in north India, the founders say they have lived and worked in Karnataka for several years and are familiar with the state’s innovation ecosystem. Their reasoning for choosing coastal Karnataka is unusually specific for a facility announcement: the region “combines clinical proximity, academic depth, and a strong talent pipeline,” which they say enables faster product development and real-world validation.
They also point to the “close clinical-engineering feedback loop” in the area and say proximity to Kasturba Medical College, Manipal has enabled direct engagement with clinicians to identify challenges and validate use cases early. The founders additionally referenced institutions such as NITK Surathkal and MIT Manipal as part of the nearby talent and research ecosystem.
What’s In The Pipeline For: Sophrosyne Technologies
In the report, Sophrosyne also signals longer-horizon ambition: it plans to “significantly expand” its team and capabilities over the next four to five years.
As the described development of the low-power multi-parameter SoC project at this company can be achieved, the Udupi center could potentially turn out to be a rare instance of such a health-tech hub within India, which can relate so well to both its hardware development and product development to be able to iterate in this manner.
